Noscendo GmbH

📍 Duisburg, Germany👥 50 employees💰 Last funded Jan 2022
Biotechnology🌐 noscendo.com
Website LinkedIn
Noscendo GmbH, a Duisburg (Germany) based molecular diagnostics company, changes the way infection causative microbes are identified. Introducing a paradigm shift using proprietary algorithms and software harnessing next generation sequencing of cell free nucleic acids isolated from patient samples Noscendo brings the concept of liquid biopsy into the field of infectious diseases. Noscendo’ s software solution is capable of differentiating infection from non-infectious signals and thereby aiding intensive care clinicians in their daily task to find the right decisions, enabling a targeted and successful treatment in an actionable timeframe.
4
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Germany
3
United States
1
Investor activity2016–2022 · investors recorded per year
201612019220221
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Noscendo GmbH?
Noscendo GmbH has 4 investors on record on gritt.io.
When did Noscendo GmbH last raise funding?
The most recent investment in Noscendo GmbH recorded on gritt.io was in January 2022.
What industry is Noscendo GmbH in?
Noscendo GmbH operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Noscendo GmbH based?
Noscendo GmbH is headquartered in Duisburg, Germany.